Small-molecule factor D inhibitors targeting the alternative complement pathway

被引：0

作者：

Jürgen Maibaum

Sha-Mei Liao

Anna Vulpetti

Nils Ostermann

Stefan Randl

Simon Rüdisser

Edwige Lorthiois

Paul Erbel

Bernd Kinzel

Fabrice A Kolb

Samuel Barbieri

Julia Wagner

Corinne Durand

Kamal Fettis

Solene Dussauge

Nicola Hughes

Omar Delgado

Ulrich Hommel

Ty Gould

Aengus Mac Sweeney

Bernd Gerhartz

Frederic Cumin

Stefanie Flohr

Anna Schubart

Bruce Jaffee

Richard Harrison

Antonio Maria Risitano

Jörg Eder

Karen Anderson

机构：

[1] Novartis Institutes for BioMedical Research,Drug Discovery Department

[2] Novartis Pharma AG,Department of Clinical Medicine and Surgery, Division of Hematology

[3] Novartis Campus,undefined

[4] Novartis Institutes for BioMedical Research,undefined

[5] Evonik Japan Co.,undefined

[6] Shinjuku-ku,undefined

[7] Pharma Research and Early Development,undefined

[8] Roche Innovation Center Basel,undefined

[9] Actelion Pharmaceuticals Ltd.,undefined

[10] Institute of Infection and Immunity,undefined

[11] School of Medicine,undefined

[12] Cardiff University,undefined

[13] Henry Wellcome Building,undefined

[14] Heath Park,undefined

[15] University of Naples,undefined

来源：

Nature Chemical Biology | 2016年 / 12卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A fragment-based design approach identifies reversible inhibitors targeting human protease complement factor D (FD), which is required for amplification of complement C3 signaling. FD inhibitors act as systemic regulators of complement activation in vivo.[graphic not available: see fulltext]

引用

页码：1105 / 1110

页数：5

共 50 条

[31] Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
Chen, Hao
Smaill, Jeff B.
Liu, Tongzheng
Ding, Ke
Lu, Xiaoyun
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14404 - 14424
[32] Development of small-molecule inhibitors targeting adipose triglyceride lipase
Nicole Mayer
Martina Schweiger
Matthias Romauch
Gernot F Grabner
Thomas O Eichmann
Elisabeth Fuchs
Jakov Ivkovic
Christoph Heier
Irina Mrak
Achim Lass
Gerald Höfler
Christian Fledelius
Rudolf Zechner
Robert Zimmermann
Rolf Breinbauer
Nature Chemical Biology, 2013, 9 : 785 - 787
[33] Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors
Qi, Jing
Dong, Zizheng
Liu, Jianguo
Peery, Robert C.
Zhang, Shaobo
Liu, Jing-Yuan
Zhang, Jian-Ting
CANCER RESEARCH, 2016, 76 (02) : 453 - 462
[34] Small-molecule inhibitors specifically targeting type III secretion
Nordfelth, R
Kauppi, AM
Norberg, HA
Wolf-Watz, H
Elofsson, M
INFECTION AND IMMUNITY, 2005, 73 (05) : 3104 - 3114
[35] Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Jia, Xiaofeng
Zhou, Hong
CURRENT PROTEIN & PEPTIDE SCIENCE, 2021, 22 (07) : 559 - 566
[36] Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Alexander J. Muller
Peggy A. Scherle
Nature Reviews Cancer, 2006, 6 : 613 - 625
[37] Development of small-molecule inhibitors targeting adipose triglyceride lipase
Mayer, Nicole
Schweiger, Martina
Romauch, Matthias
Grabner, Gernot F.
Eichmann, Thomas O.
Fuchs, Elisabeth
Ivkovic, Jakov
Heier, Christoph
Mrak, Irina
Lass, Achim
Hoefler, Gerald
Fledelius, Christian
Zechner, Rudolf
Zimmermann, Robert
Breinbauer, Rolf
NATURE CHEMICAL BIOLOGY, 2013, 9 (12) : 785 - +
[38] Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Muller, Alexander J.
Scherle, Peggy A.
NATURE REVIEWS CANCER, 2006, 6 (08) : 613 - 625
[39] Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases
Hua, Dexiang
Wu, Xiaoxing
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 233
[40] Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
Moon, Seonghyeon
Muniyappan, Srinivasan
Lee, Sung-Bae
Lee, Byung-Hoon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)

← 1 2 3 4 5 →